Document is current
Any future updates will be listed below
-
Authors
Jobanputra, Vaidehi http://orcid.org/0000-0003-0962-7873
Schroeder, Brock http://orcid.org/0000-0002-0803-7209
Rehm, Heidi L. http://orcid.org/0000-0002-6025-0015
Shen, Wei
Spiteri, Elizabeth
Nakouzi, Ghunwa
Taylor, Stacie http://orcid.org/0000-0001-6843-3505
Marshall, Christian R. http://orcid.org/0000-0002-4003-7671
Meng, Linyan
Kingsmore, Stephen F. http://orcid.org/0000-0001-7180-2527
Ellsworth, Katarzyna http://orcid.org/0000-0001-6269-4771
Ashley, Euan
Taft, Ryan J.
,
- License Information
-
More Information
Article History
Received: 5 October 2023
Accepted: 8 March 2024
First Online: 27 March 2024
Competing interests
: Christian Marshall and Vaidehi Jobanputra report receiving consulting fees from Illumina Inc. Heidi Rehm receives research funding from Illumina and Microsoft. Brock Schroeder, Stacie Taylor, and Ryan Taft are employees and stockholders of Illumina Inc. Euan Ashley reports the following competing interests: Personalis, Deepcell, Svexa, RCD Co (founder); SequenceBio, Foresite Labs, PacBio, Apple (advisor); AstraZeneca (nonexecutive director); Oxford Nanopore, Pacific Biosciences, AstraZeneca (stock); Illumina, Pacific Biosciences, Oxford Nanopore (in kind collaborative support).
